InVitro International reported a 5.3% increase in sales for Q2 FY 2026, reaching $206,840, and a 14.7% rise in net income compared to the same quarter last year. However, year-to-date sales are down 11.6% compared to the first half of FY 2025, and net income for the first half of FY 2026 is 42.8% lower than the previous year. The CEO highlighted progress in the company's strategic direction and optimism about growing global acceptance of their non-animal testing technologies. InVitro aims to continue its streak of profitability while expanding its market reach amid changing regulatory policies.
Fangzhou Inc. has launched Kyinsu®, the world's first once-weekly basal insulin/GLP-1 receptor agonist combination therapy, on its AI-powered Internet hospital platform in China, the first global market for this treatment. This therapy reduces insuli...
Bitcoin options data reveals a bullish medium-term outlook with call options dominating open interest, signaling trader confidence in price gains. However, recent trading shows increased put option volume, indicating that traders are hedging against ...
Eva Live Inc. announced a plan to acquire a 51% stake in Airbeam Wireless Technologies for about $16 million, with an option to buy the rest. This move gives Eva Live access to over 260 patents and advanced millimeter-wave technology, accelerating it...
Bitcoin has recovered from a July 1 low of $57,800 to trade around $64,000, supported by long-term holders who are holding rather than selling. The current price zone is defended by traders to avoid losses, but the market floor is still forming. Key ...
Bombardier's Global 8000 business jet set a new speed record flying from Los Angeles to Farnborough, UK, completing the journey in 8 hours and 46 minutes despite unfavorable tailwinds. The aircraft reached a top speed of Mach 0.93, beating the previo...
